- TWD6.89bn
- TWD13.08bn
- TWD2.50bn
- 41
- 32
- 44
- 28
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,937 | 5,307 | 1,528 | 547 | 2,503 |
Cost of Revenue | |||||
Gross Profit | 771 | 826 | 558 | 155 | 675 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4,933 | 5,258 | 1,193 | 557 | 2,156 |
Operating Profit | 4.22 | 48.1 | 335 | -9.36 | 346 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 405 | 117 | 490 | 174 | 531 |
Provision for Income Taxes | |||||
Net Income After Taxes | 359 | 122 | 478 | 138 | 427 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 186 | 154 | 480 | 141 | 426 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 186 | 154 | 480 | 141 | 426 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.256 | 0.509 | 1.8 | 0.536 | 1.63 |
Dividends per Share | |||||
Special Dividends per Share |